MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 280 filers reported holding MYRIAD GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,217,000 | -20.2% | 105,128 | -2.3% | 0.12% | -10.9% |
| Q1 2016 | $4,029,000 | +111.5% | 107,654 | +143.9% | 0.14% | +132.2% |
| Q4 2015 | $1,905,000 | -25.7% | 44,135 | -35.5% | 0.06% | -24.4% |
| Q3 2015 | $2,565,000 | -56.0% | 68,436 | -60.1% | 0.08% | -47.7% |
| Q2 2015 | $5,830,000 | -8.7% | 171,505 | -4.9% | 0.15% | -7.5% |
| Q1 2015 | $6,384,000 | +19.5% | 180,317 | +15.0% | 0.16% | +42.5% |
| Q4 2014 | $5,342,000 | +2.8% | 156,833 | +16.5% | 0.11% | +8.7% |
| Q3 2014 | $5,194,000 | +21.0% | 134,660 | +22.1% | 0.10% | +22.4% |
| Q2 2014 | $4,294,000 | +207.8% | 110,325 | +170.5% | 0.08% | +157.6% |
| Q1 2014 | $1,395,000 | +16.7% | 40,790 | -28.4% | 0.03% | +17.9% |
| Q4 2013 | $1,195,000 | – | 56,990 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |